safe are hope for thank and joining us. Thanks, you morning, you and everyone, Good well. Matt. We
Before to am reviewing to the financials, a on than joined lead providing like because honored I and I have my more a founding, help it to opportunity children. I I'd ago its moment to a was felt OP so how I calling did years forward. XX take the business just life after to update and say OrthoPediatrics
As take children. by of I new on we've to this I improve responsibility, all lives am accomplished the humbled
know, the cause you of the founded As conditions. orthopedic was on children of lives improving OrthoPediatrics with
share pediatric have partnered in this cause. surgery Over to opinion with in our of field from the we the world, the years, orthopedic leaders dedication who key around
far, to While of we much best accomplishments that proud children ensure we our do the have thus are more access care. there can health is so to
our let you, prepared our delivery results. like we to our Fred company there do remarks that but personal also quarterly quarterly his your a last and no With our friend. will turn We and Mark's successes. new in can represent. and very mentor and the thank guidance who best. building instrumental is we leadership, a take has also are match Chairman, early polished Executive for are incredible XX Mark service cause congratulate our Mark I in one our me and Mark Fred OrthoPediatrics call, to I his for of It's been years. commitment as what who true continued Thank said, Mark, On note, service. and has on your earnings are to over story, an and been and to a for that our I'd to on past build to still time this Throdahl, excited growth
since children helped the a more bringing XXXX, the OrthoPediatrics. of to to that in are report the XXX,XXX total number quarter we proud record than We XX,XXX inception second of
this unusually of company proud large very our for is which of Our a team size. number, is
so And our business the of as this with ultimate lead built which a represents call to off measure quarterly success statistic, every on we intend that cause.
our We extremely OrthoPediatrics environment. pleased associates the to demanding continue as are of representing record of to generated growth second compared posted second to results operating execute XX% also $XX.X quarterly in this revenue In report quarterly quarter, quarter that we million the of XXXX.
trends XX% the a COVID-XX. of We surgery second pediatric the growth from robust to second testament second three to have in and revenues domestic year markets. up the million, levels generated businesses, U.S. significantly -- and and strength appear in all orthopedic our is As million, surgeons team. volumes strength prior and worked of XXX% XXXX, the backlog. $X our reminder, was a this the the quarter in resiliency Achieving clinic the quarter milestone driven as We In $XX.X was business market This of to that visits by have prior quarter through normalized the to XXXX. quarter international of was impacted quarter revenue improved much the largely XXXX. increase a believe fundamental compared of of international of U.S. pre-COVID by
the pleased continued market, U.S. be we leading international COVID, unlike While are to increased with our quarter-to-quarter. quarter, performance negatively impacted variability to in the by
international their their most while work belief XX least our have it will of Additionally, that through at U.S. cases, backlog believe through we markets surgeons to take backlog. months worked is
our past Since years growth, consistent have we deliver becoming over decade. XXXX Lastly, to set aggregate, has now provide a our with on a double-digit strengthened is us by the revenue update purchases strategic ago, four our nearly below always initiatives. remain long-term distributors. an set been their record deployment ability international public stocking levels. methodically track indicator for company I'll which still In leading durable,
corporate forward, our will change. strategy not Moving
number treat on majority the on world two, to designed of strong five robust pediatric support already through a and hospitals pillars surrounding which clinical meet needs number market product portfolio with sets orthopedic surgeons. include: Our around select focus pediatric and remain three, number market demand; children; the and focusing of M&A treat education finally, number program one, addressable pediatric five, expanding unmet deploying and will R&D children's number meeting investment instrument train academic patients; in the the of orthopedic broad that to uniquely and surgeons centers growth, high-volume opportunities; sales our personnel expanding and to aggressive next-generation four, the
strategy simple and will Our to disciplined continue to is proven, and a it in allow execute us manner.
With of This deviate RESPONSE complex excess product Going we announced to our provide and instrumentation to platform. the challenges surgical fixation. patient the options in also latest extreme to implants in System, the developed RESPONSE to its stability was population. no of treatment Neuromuscular base system provides the Building we procedures, deformity This this forward, is set these extremely Neuromuscular specific spinal unique is and help orthopedic portfolio specific addition RESPONSE sacropelvic to our the RESPONSE reason annual procedures. Spine challenging Scoliosis XXth dedicated simplify instruments conjunction the RESPONSE continued expansion, on of optimize features and and neuromuscular respect with address treating speed Neuromuscular see growth system. correction in improve address system has surgeons The new launched since produced NM Scoliosis of outcomes. with XX% was that or that of hyperlordosis the thus these consistent represents the designed to RESPONSE from founding. the greater product of pediatric and since the May, launch complete a the and OrthoPediatrics inception formula to scoliosis has
launch, While still the key early our in commercial positive. has from customers its reception been very
solution System. Cannulated the mid-June, pediatric full Screw This SCFE system treating release for capital Additionally, our commercial as slipped we in collaboration a femoral with surgeons of traumatic in was designed announced epiphysis. orthopedic
our system fully other with instead on in threaded the offers surgeon flexibility partially X-millimeter range SCFE this surgeons making market, to X.X needs options virtually unique our screws orthopedic providing a various treat effectively. implant our first leading We more EMEA Trauma and SCFE Germany fully screws what's injuries to and Specifically, of major of markets the screws Orthex service Deformity fixation simply we in now roll sizes to our the are incorporate U.K. all help patients the also from more threaded region, out cannulated pediatric surgeon. screws. X.X to with in of the a offer features treat external the increments, thread available. that the business, to threaded Unlike The millimeters systems wide remove of to with millimeters with cases do available properly and lengths Within continue ranging pediatric systems
on we've impact to have EMEA Brazil. positive to Canada, what Australia seen the launch XXXX, and a expect We similar continue that Orthex to in
leading clinical the to lower was in outcomes ability Columbia paper significantly first reduce a cost. at Orthex from improved Canada. infection Orthex to of recognized patient publication its Children's rates, highlighted This Hospital Additionally, Vancouver, British in
quarter, post subsequently from initiate both approvals, new risk settlement the has the which Stryker, the expenses with in users. We enroll four KXM ApiFix with U.S. outstanding participating considerable incurring agreement continue settlement the This ApiFix in an or clinical the and have the in registry required to now second Transitioning PAS us approval for enabling locations patients registry. years. study, game-changing added past finalized being and we Lastly, clinical sites exposed our to technology. to we In been IRB to issue those XX legal locations future. saves
have XX us expect receive of approvals months, To target surgery. for in strength. the three registry their at an scheduled cases next to final cases XX been completed the additional approved with putting remaining registry sites date, few XXX the We full or
the early still months XX X-year least our surgery are patients first so clinical far, past more past days, dates. U.S. by is and outcomes than sites patient June, the delighted their with seen past follow-up their this it While we've at six
as COVID-related reoperations continued approvals important device-related and taken which delays sites IRB zero very to technology, had approach pace registry have XX the expect we one have conservative have reported with impacted to experience It's sites, We our Furthermore, no also to scheduling. many revisions. patient selection a note that of or the to at scheduling. and of have might game-changing complications a
six and required of PAS already training, target to patient, sites and sites with ApiFix to IRB the year. parallel commercial ApiFix's commercial These half the Exemption cases system to the meet the of the process selection IRB success start these our the have the intend actual new a the of two completion to not registry. we is prior second Due being next initiated of family surgeon onboarding which as approval and burden We expect XXX as requirements. commercial cases. for approval XX XX Humanitarian by have Given of will second early clinical dynamics, in demand the plan early next scheduling and patient PAS registry are to XXX the first the the Device release registration XXXX, single of to of in contend well
second the In Now turning and development. to we execute deployment set continued of set to strategy quarter, deployment. force sales our
first now million in Specifically, the $X.X we their we second the compared of domestic anticipate quarter, our lower XXX sets compared of quarter second reps $XX of new consigned significant XXXX, were million business. second recruitment the the Further by quarter confidence our of second of QX investment $X half XXXX. have years of lower recent to of $XX efforts Orthex with in XXX deployments and and count return million on many during of Year-to-date, million sales in to head the million sales our ApiFix of underscoring of are in to compared to of domestic recovery instrumentation deployed set organization $X.X number hired XXXX, in cost in partners, the greater from In five XXXX XXXX. the sets. sales grew reps a underway because quarter to somewhat We XXXX, XXXX. $X.X million
to in in be smaller earlier before may the countries. After XX announced XX year. we through are sales Switzerland U.S. XX continues of conversion and products the work and several expect in which of Germany, countries stocking agency the over in this year. our the of be to end the will of United agencies normalize, conversions, the announced selling increased XX States, distributors As associates coming market number added Outside on an XX year, Austria major we continue countries we
our also XD also pedicle front, enabling on with work of M&A guide from our other franchise to which evaluate while extension we the future, technologies agreement FIREFLY, On in announce Medical, we distribution the are very secures continue patient-specific pleased Oak us the several screw interesting projects, to navigation printed Mighty to but recently sources. important
meeting and education focused North and surgeon Orthopedic in investing clinical sales on annual turning to we Lastly, Dallas. attended We or In remain train partners. our to America support the meeting, initiatives. May, Society resources POSNA Pediatric of
of support residents Sponsor, the a meeting. to Subspecialty Diamond eight we fellows ongoing As awarded for double a scholarships Day provided attend Symposia, and and
and of with our partnership ongoing surgical orthopedic societies. POSNA proud are supporting pediatric We
to education the external Dallas. fixation in events, our highlight hosting this June live past return was quarter education an in Another and clinical seminar
from hands-on very surgeon expert discussions colleagues. and attendees sessions around States fixation likely from XXX% the their the Our and highlighting lectures, and surgeon survey faculty were hosted United to was Feedback course that of external to attendees or respondents positive, stated this Orthex likely overwhelmingly the in recommend they system.
Additionally, second hospital sales in force efficient use products critical in operating staff and the effective sessions are XX residents, fellows, room. and attendings the sessions OrthoPediatrics the field our product than conducted for quarter, education more members. and clinical These with of
more entire selling field to of partner our product. market pediatric mission pediatric As surgeons to not the in our orthopedics, orthopedic a leader, is just advancing of believe with it we integral
collaboration commitment initiatives partnerships clinical Our fosters mutual thus stronger objective. education with and this surgeons, to furthering
ahead, am of our OrthoPediatrics. As has proud how since much achieved I I look we joined team
business built products children's growth innovative, a that lives. have We improve strong from delivers that differentiated
We of are this our market. record pleased large the sustained of we double-digit are in still growth. underserved But very with penetrating innings early revenue track
our strategy, our As over kids provide we continue help Fred financial confident With our the proven fact, in call accelerate ability to I'll and results. execute that, to more deliver more we and, turn on in of growth detail worldwide. to Fred? remain to lives the growth
